MOdularity for SEnsory Motor Control (MOSE)

June 7, 2022 updated by: Andrea Turolla, IRCCS San Camillo, Venezia, Italy

MOdularity for SEnsory Motor Control: Implications of Muscle Synergies in Motor Recovery After Stroke

For this project the investigators ask, how the activation and organization of muscle synergies may be disrupted by brain lesions, and whether it is possible to modify synergy activations by means of specific therapies. Will be investigated whether there is a relationship between post-stroke cortical plasticity and changes in synergy activations due to a therapy.

Study Overview

Detailed Description

It has been widely recognized that neurorehabilitation can facilitate recovery of motor function after stroke. There has been increasing evidence suggesting that the execution of voluntary movement relies critically on the functional integration of the motor areas and the spinal circuitries. More precisely, it was suggested that the central nervous system may generate neural motor commands through a linear combination of spinal modules, each of which activates a group of muscles as a single unit (muscle synergy). The investigators hypothesize that descending motor cortical signals generate movements by combining and activating muscle synergies. With this background, the goal is to further improve the efficacy of rehabilitation utilizing knowledge on modular motor control. The investigators also seek to provide a better understanding of the links between brain activations and movements.

The project MO-SE has three aims, one primary and two secondary. The main primary aim is to test whether the use of virtual reality rehabilitation based therapies are superior in terms of clinical efficacy to conventional therapies (randomized clinica trial, RCT). The other two secondary aims of the project will be accomplished with further instrumental analysis in sub-samples of the group of patients enrolled for the RCT.

Study Type

Interventional

Enrollment (Anticipated)

132

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Milan, Italy
        • IRCCS Fondazione Don Gnocchi ONLUS
      • Venice, Italy, 30126
        • IRCCS San Camillo, Venezia, Italy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • diagnosis of first stroke;
  • a score between 1 and 3 (included) at the upper limb sub-item on the Italian version of the National Institute of Health stroke scale (IT - NIHSS) (Pezzella et al., 2009)
  • a score higher than 6 out of 66 on the Fugl - Meyer upper extremity (F-M UE) scale (Fugl-Meyer et al., 1975).

Exclusion Criteria:

  • the presence of a moderate cognitive decline defined as a Mini Mental State Examination (Folstein et al., 1975) score < 20/30 points;
  • the finding of severe verbal comprehension deficit defined as a number of errors > 13 (Tau Points < 58/78) on the Token Test (Huber et al., 1984);
  • evidence of apraxia and visuospatial neglect interfering with upper arm movements and manipulation of simple objects in all the directions within the visual field, as assessed through neurological examination;
  • report in the patient's clinical history or evidence from the neurological examination of behavioural disturbances (i.e. delusions, aggressiveness and severe apathy/depression) that could affect compliance with the rehabilitation programs;
  • non stabilised fractures;
  • diagnosis of depression/delusion;
  • associated traumatic brain injury;
  • drug resistant epilepsy;
  • evidence of ideomotor apraxia;
  • evidence of visuospatial neglect;
  • severe impairment of verbal comprehension defined as a score higher than 13 errors on Token test (i.e. score<58 out of 78 Tau points).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Technology-aided rehabilitation
The technology-aided upper limb rehabilitation include reinforced feedback in virtual environment (RFVE), or robotic therapy.

VRRS involves performing different kinds of motor tasks with the patient holding a real manipulable object in their hands while interacting with a virtual scenario.

"Braccio di Ferro" task consists in center-out reaching movements and return. The subject is required to start from a central target, reach one of five peripheral targets arranged on a semi-circle with a 20 cm radius and then return to the central target.

Other Names:
  • Virtual Reality Rehabilitation System (VRRS)
  • Braccio di Ferro
Active Comparator: Conventional rehabilitation
The conventional upper limb rehabilitation program will be based on traditional rehabilitation techniques aimed at restoring upper limb motor functions.
The patients will be asked to perform a wide range of exercises, including: shoulder flexion-extension, abduction-adduction, internal-external rotation, circumduction, elbow flexion-extension, forearm pronation-supination, hand-digit motion. Standardized instructions and modalities will be followed when providing exercises to the patients in order to control for any variability in leading the therapy session due to the therapist.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fugl-Meyer Assessment Scale - Upper Extremity (construct: upper limb motor function)
Time Frame: 20 days
Scale range scores: 0 - 66 points. Total summed score is reported with higher values representing a better outcome.
20 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Independence Measure (FIM) (construct: measure for independence in the activities of daily living - ADLs)
Time Frame: 20 days
Scale range scores: 18 - 126 points. Total summed score is reported with higher values representing a better outcome.
20 days
Fugl-Meyer Assessment Scale - Range of Motion of Joints (construct: measure joints' passive range of motion)
Time Frame: 20 days
Scale range scores: 0 - 44 points. Total summed score is reported with higher values representing a better outcome.
20 days
Fugl-Meyer Assessment Scale - Sensory Function (construct: measure of residual sensory function in upper and lower limbs affected by paresis)
Time Frame: 20 days
Scale range scores: 0 - 24 points. Total summed score is reported with higher values representing a better outcome.
20 days
Fugl-Meyer Assessment Scale - Balance (construct: measure of impairment of standing and balance functions)
Time Frame: 20 days
Scale range scores: 0 - 14 points. Total summed score is reported with higher values representing a better outcome.
20 days
Reaching Performance Scale (construct: measure of the ability to reach targets in the frontal space of upper limb affected by paresis)
Time Frame: 20 days
Scale range scores: 0 - 36 points. Total summed score is reported with higher values representing a better outcome.
20 days
Modified Ashworth Scale (construct: measure of spasticity at the upper limb)
Time Frame: 20 days
Scale range scores: 0 - 5 ranks. Total summed ranks are reported with higher values representing a worse outcome.
20 days
Box and Block Test
Time Frame: 20 days
Measure of gross motor function of the hand and upper limb
20 days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean duration [s]
Time Frame: 20 days
Time needed to execute standard motor tasks
20 days
Mean velocity [cm/s]
Time Frame: 20 days
Velocity expressed to execute standard motor tasks
20 days
Smoothness [number of submovements]
Time Frame: 20 days
Smoothness expressed to execute standard motor tasks
20 days
Muscle synergies [n]
Time Frame: 20 days
Number of muscular patterns recognised by processing of surface electromyography data to execute standard motor tasks
20 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2014

Primary Completion (Actual)

December 1, 2018

Study Completion (Anticipated)

December 1, 2022

Study Registration Dates

First Submitted

May 8, 2018

First Submitted That Met QC Criteria

May 8, 2018

First Posted (Actual)

May 21, 2018

Study Record Updates

Last Update Posted (Actual)

June 8, 2022

Last Update Submitted That Met QC Criteria

June 7, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2015.14
  • 16/GR-2011-02348942 (Other Grant/Funding Number: Ministero della Salute, Italy)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rehabilitation

Clinical Trials on Technology-aided rehabilitation

3
Subscribe